A service provider removes inserted family planning option from a client after its expiration at centre Igboro health facility in Ilorin in Nigeria’s central state of Kwara. © 2012 Akintunde Akinleye/NURHI, Courtesy of Photoshare
Contraceptive implants are available to more women around the world than ever before, thanks in large part to the Implant Access Program (IAP), a collaboration among several donor agencies, governments, non-governmental agencies (NGOs), and the makers of the contraceptive implants Jadelle® (Bayer HealthCare AG) and Implanon®/Implanon NXT® (Merck/MSD) to lower the products’ unit price by 50% for the world’s poorest countries. Since the launch of the IAP in 2013, 25.2 million implants have been purchased under this price reduction. Corresponding increases in implant use reported in national surveys such as the Performance, Monitoring & Accountability 2020 (PMA2020) indicate that women are taking advantage of the new found accessibility of affordable implants. Prevalence of implant use among married women has increased by 39% and 44% in Ethiopia and Kenya, respectively, in the last two years, and implants are currently the most commonly used method in Burkina Faso.